Mobile Health Technology-Enabled AFib Management
Launched by JOHNS HOPKINS UNIVERSITY · Jul 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new digital tool designed to help people manage atrial fibrillation (AFib), a condition where the heart beats irregularly. The goal is to see if using this tool can improve people's quality of life and help them better handle their AFib episodes. Participants will learn about different treatment options and lifestyle changes that can help them feel better and manage their condition more effectively.
To join the study, participants need to be 18 years or older and have a diagnosis of paroxysmal AFib (which lasts less than a week) or persistent AFib (which lasts longer than a week). They should also have a body mass index (BMI) of 27 or higher. However, individuals with certain heart issues, prior heart surgeries, or who have specific medical devices implanted may not be eligible. Those who participate can expect to use the digital tool and receive support as they navigate their AFib management. This study is currently not recruiting, so interested individuals should keep an eye out for updates on when it will begin.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 18 or older at time of consent
- • 2. Diagnosis of paroxysmal (Afib lasting less than 7 days) or persistent (7 days or longer) atrial fibrillation
- • 3. BMI (Body Mass Index) ≥ 27.0
- Exclusion Criteria:
- • 1. Permanent Afib (decision has been made not to attempt sinus rhythm)
- • 2. Severe valvular disease
- • 3. Moderate mitral valve stenosis
- • 4. Prior cardiac surgery
- • 5. Presence of implanted cardiac device
- • 6. History of cardiac arrest
- • 7. Left ventricular ejection fraction (LVEF) ≤ 35%
- • 8. Life expectancy \< 1 year
- • 9. Non-English speaking
- • 10. Treating clinician deems unsafe for exercise
- • 11. Any other reason that makes patient unsuitable for study at the discretion of the PI
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Patients applied
Trial Officials
David Spragg, MD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported